2-BLOGS: Audit-Package Delivered, MyFlix, Form 10, Uplist

New Post Public Reply Private Reply Replies (0) Message Board
speckulater
346
2-BLOGS: Audit-Package Delivered , MyFlix, Form 10, Uplist OTC:QB





TO BE CLEAR: THE AUDIT PACKAGE IS DELIVERED TO OUR REPUTABLE (PCAOB CERTIFIED) AUDITORS!





kcobghhseblog.png



BLOG: AUDIT PACKAGE DELIVERED TO REPUTABLE (PCAOB-CERTIFIED) AUDITORS!


Thursday, June 28, 2018

Delivering the HHSE Audit Package feels a bit like the final scene from "Indiana Jones"

At long last, the HHSE Audit package has been completed and has been delivered by courier today (it was "after business hours" tonight when the final alphabetizing of the file folders was completed) Some aspects of the prep for this project were relatively easy... such as the electronically delivered Quickbooks ledger of sales and payables, and scans of 1120-S filings. But other items - such as the reconciliation of producer recoupment positions for over 450 titles (many going back to 2005) - as well as the copying and collating of agreements (which averaged 12-pages per title, plus term renewals). For these more voluminous elements, a physical copy from Fedex office was more expeditious than the time that would have been required to scan, upload and download more than 4,000 pages of supporting agreements.

But it's done, and we can all now set our sights on a prompt filing of our Form 10 Registration Statement - timed to correspond with our peak consumer promotions for MYFLIX in early August.

TO BE CLEAR: THE AUDIT PACKAGE IS DELIVERED TO OUR REPUTABLE (PCAOB CERTIFIED) AUDITORS!


Stay tuned for updates! Onward & Upward!


Raiders-of-the-Lost-Ark%2B%25281%2529.gif


Okay... so maybe it's not QUITE as daunting as the Indiana Jones warehouse image... but a LOT of work, copying, collating and organizing went into the completion of the HHSE audit package!


HHSE%2BAudit%2BBoxes.jpg



http://hannoverhousemovies.blogspot.com/2018/...s-bit.html








kcobghhseblog.png



BLOG: MyFlix, Form-10/Audit Uplist-OTC:QB, No-Dilution, Sony/Cinedigm Partnerships, Undervalued

Friday, June 29, 2018

July looks to be a busy time for HHSE!


Happy Friday to our HHSE Friends & Followers - Corporate movements are kicking into third gear for July, with material activities on multiple fronts, and lots of meetings and travel support.

The Launch of MYFLIX requires two L.A. trips during July - plus one web-hosting visit to Seattle. The L.A. trip will also allow for some face-to-face meetings with key MYFLIX suppliers and other major studios that we are seeking to enlist. The aggressive Q3 / Q4 home video & digital release slate for the HHSE / Medallion core distribution business will also benefit from direct meetings with key wholesalers and distribution partners in the L.A. metro. And of course, we anticipate one or more day trips during July to meet with the auditors (current Form 10 project), should issues requiring clarification not be easily resolved by calls or Skype.

Hannover's original production of the Period-Thriller, THE RIOT ACT, will likely be rescheduled for theatrical release in SEPTEMBER in order to access a retail cross promotion and a College / Universities support campaign. Previously, we had planned this title for theatrical launch on Aug. 24... but the mid-to-late September date is looking more interesting. HHSE / Medallion also have two other titles for theatrical release - both planned for OCTOBER (neither acquisition has yet been announced, so out of respect for the stature of the films, the company will announce the titles via separate wire-services press releases).

With all of this exciting activity and results, some current and prospective shareholders are asking about the HHSE stock and timing. Accordingly, we share with you below the summation of notes from large traders / professional funds that have been in communication with HHSE management over the past few months.

WHY IS THIS A GREAT TIME TO LOOK AT HHSE?

1). STABILITY -
Company has been in business for 25-years (since 1993).

2). DIVERSITY - Original business of BOOK PUBLISHING evolved into DVD Distribution and now into THEATRICAL and INTERNATIONAL Distribution as market conditions changed.

3). NEW MEDIA - the new MYFLIX Venture into digital streaming http://www.MyFlix.com has over 30-studio and film library participants, collectively with over 10,000 feature films and television episodic hours of entertainment. This platform will have (literally) THOUSANDS of movies not available on any other streaming site. Less than ten years ago, NETFLIX was a mail order video rental business. NOW they are among the top movers and shakers in the entertainment industry DESPITE having a very limited selection of programming for viewers. We believe that MYFLIX could be a revolutionary new streaming destination - and a massive turning point for Hannover House.

4). STOCK REGISTRATION - HHSE is currently on the "OTC-Pinksheets" exchange. This status has impeded some large, institutional investors and hedge funds from buying into the stock. However, the pending Form 10 filing (including audits), will elevate the stock to the OTC:QB status as an initial step towards possible further up-listing. The OTC:QB status will open the door to significant new shareholders, which most professional traders and investors feel will dramatically improve the PPS and trading volume for HHSE.

5). NO STOCK ISSUANCES / NO DILUTION - HHSE has not issued any new shares in the past three years, and management has repeatedly stated that there are no plans to dilute shareholders through any deals now in motion or anticipated in the future.

6). PRESENTLY UNDER-VALUED PPS - Based on the Price-Earnings ratio for other publicly traded film / entertainment distributors, HHSE should be enjoying a 22X share price based on earnings. HHSE is on target to realize $1,250,000 in earnings for FYE 12-31-2018. This supports a share price of $.034 at present... and does not take into account the tremendous good-will and enthusiasm factor for the upcoming launch of MyFlix. Some highly respected stock analysts have communicated to HHSE management their prediction that the company's activities could support a share price of $.15 - which is more than ten-times current pricing. Even if their predictions are off by 75% - there is still an easily justifiable share price that is many times more than current trading levels.

7). TIMING-TIMING-TIMING - The launch of Myflix is a "second generation" site, in that the digital streaming technology and consumer acceptance have already been established. With that essential battle already won, MyFlix can concentrate on becoming "the better mousetrap" for digital entertainment. You combine this ideal market timing with the company's stock registration uplist, the presence of significant new shareholders post-registration, and new distribution pacts for the company's core film distribution activities (SONY / CINEDIGM), many feel that NOW is the ideal time to take a position in HHSE shares (while the HHSE Price Per Share is artificially low). Are these professional traders right? We will all know very soon!

HHSE makes no representation, guarantee or warranty that our share price will improve significantly as a result of these and other current activities. Every stock investment involves risks and factors outside of the control of issuers and management. But we proudly share with you the above information, projections and rationale' that professional traders have identified as the basis for why they believe that NOW is a great time to look at HHSE.

CHECK THIS BLOG SITE FOR REGULAR UPDATES ON HHSE and MYFLIX!


http://hannoverhousemovies.blogspot.com/2018/...-hhse.html



Myflix-Log-Blue%2B%25281%2529.jpg


HHSE%2BKey%2BArt%2BSelected%2B2018%2BItems.jpg


Stock%2BChart.jpg







HHSE

Hannover House Inc. (HHSE) Stock Research Links

HHSE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading

Top 5 Most Recently Viewed Articles

BioVaxys Unveils Private Placement to Boost Growth Initiatives

Updated Category News Views 83

BioVaxys Technology Corp. Announces Private Placement Offering BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) is thrilled to share its plans for a strategic move that aims to elevate its operational capabilities. The company intends to initiate a non-brokered private placement offering, introducing up to 14,285,715 units at a price of CAD$0.07 each. This initiative is...

Continue Reading
Cardiff Oncology Secures $40 Million Through Oversubscribed Offering

Updated Category News Views 104

Cardiff Oncology Completes Significant Stock Offering Cardiff Oncology, Inc. (Nasdaq: CRDF) has recently made headlines with its successful pricing of an underwritten offering, targeting a remarkable $40 million. This offering consists of 15,384,619 shares of its common stock, priced at $2.60 per share, with all shares being offered by the Company itself. The...

Continue Reading
Sungrow and Globeleq Partner for Major Battery Storage Project

Updated Category News Views 301

Sungrow and Globeleq Join Forces on Groundbreaking Energy Project Sungrow, a prominent name in the renewable energy sector, and Globeleq, a trusted independent power producer, have made a significant commitment by signing a term sheet. This partnership focuses on the supply and long-term service for the ambitious 153MW / 612MWh Red Sands Battery Energy Storage System...

Continue Reading
Helios Technologies Unveils the Advanced S35 Display System

Updated Category News Views 442

Helios Technologies Launches the Versatile S35 Display Helios Technologies, Inc. (NYSE: HLIO), known for its expertise in highly engineered motion control and electronic controls technology, has recently introduced the S35 display. This new addition showcases a unique blend of advanced technology, rugged durability, and user-friendliness, making it an exceptional...

Continue Reading
Ameriprise Financial Soars to New Heights: Stock Insights

Updated Category News Views 47

Ameriprise Financial Achieves All-Time High Ameriprise Financial Inc (NYSE: AMP) has recently marked an extraordinary achievement with its stock price reaching an all-time high of $524.01. This significant increase not only highlights the company’s performance but also reflects a robust surge in investor confidence, demonstrated by a remarkable 65.08% increase over the...

Continue Reading